Fosun International LTD Corvus Pharmaceuticals, Inc. Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$3.01 - $6.5 $554,189 - $1.2 Million	-184,116 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$3.3 - $4.58 $43,368 - $60,190	13,142 Added 7.69%	184,116 $624,000
Q1 2019 May 10, 2019	BUY	$3.75 - $4.97 $44,970 - $59,600	11,992 Added 7.54%	170,974 $669,000
Q4 2018 Jan 31, 2019	BUY	$3.29 - $8.94 $523,050 - $1.42 Million	158,982 New	158,982 $523,000

30.4M

1.06M

84.3K

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $223M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.